End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.31 CNY | +3.74% | +9.91% | -34.69% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- With an expected P/E ratio at 40.33 and 30.95 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-34.69% | 162M | - | ||
-17.52% | 12.76B | - | ||
-41.64% | 2.67B | C- | ||
-9.49% | 2.55B | - | ||
-20.49% | 1.32B | - | - | |
-.--% | 1.12B | - | - | |
+77.44% | 465M | B+ | ||
+19.47% | 440M | - | ||
+31.39% | 282M | C | ||
+7.78% | 193M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 688607 Stock
- Ratings CareRay Digital Medical Technology Co., Ltd.